A nice summary of the action that occurred in the first week of the trial in today's NY Times.
I've had the chance to talk with a few trial lawyers who have
personally been down in Texas to see a few days of the trial and their
analysis is a little different then the Times reporter, who essentially
feels that Merck with stood the first week pretty well, and that
Attorney Lanier has taken a risk by not laying out his case in
sequential order, but instead opting for a thematic approach to telling
his story. Having seen Attorney Lanier in action on other matters
i'll trust his judgement on this one, as he is clearly one of the
premier trial lawyers practicing in the US, and is almost with out
parallel in reducing complex matters into understandable language that
the typical jurist can understand.
This should be a crucial week at the plaintiffs medical expert, Dr.
David Egilman, and his theory of causation. There is no question the
biggest hurdle the plaintiffs need to jump here is the concept of
clotting leading to arrhythmia, so this should be a pivotal week.
For Inquiries or Questions
